Number of the records: 1  

A novel c. 204 Ile68Met germline variant in exon 2 of the mutL homolog 1 gene in a colorectal cancer patient

  1. 1.
    SYSNO ASEP0453206
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleA novel c. 204 Ile68Met germline variant in exon 2 of the mutL homolog 1 gene in a colorectal cancer patient
    Author(s) Vodička, Pavel (UEM-P) RID
    Caja, F. (CZ)
    Vymetálková, Veronika (UEM-P) RID
    Procházka, Pavel (UEM-P) RID
    Vodičková, Ludmila (UEM-P) RID
    Schwarzová, L. (CZ)
    Slyšková, Jana (UEM-P) RID
    Kumar, R. (DE)
    Schneiderová, M. (CZ)
    Number of authors9
    Source TitleOncology Letters. - : Spandidos Publications - ISSN 1792-1074
    Roč. 9, č. 1 (2015), s. 183-186
    Number of pages4 s.
    Languageeng - English
    CountryGR - Greece
    KeywordsmutL homolog 1 ; germline mutation ; colorectal cancer
    Subject RIVEB - Genetics ; Molecular Biology
    R&D ProjectsGPP304/11/P715 GA ČR - Czech Science Foundation (CSF)
    GAP304/12/1585 GA ČR - Czech Science Foundation (CSF)
    Institutional supportUEM-P - RVO:68378041
    UT WOS000346638300031
    EID SCOPUS84911459103
    DOI https://doi.org/10.3892/ol.2014.2666
    AnnotationMutations in the mutL homolog 1 (MLH1) gene are frequent in patients with hereditary non-polyposis colorectal cancer (CRC). The MLH1 gene was screened for mutations in patients with sporadic CRC. The nucleotide sequences for all 19 exons of MLH1 were analyzed by high resolution melting and sequenced in a group of 104 sporadic CRC patients, and the results were verified in a replication group of 1,095 patients and 1,469 controls. Different melting profiles for exon 2 of the MLH1 gene were observed in the germline DNA of one patient. Sequencing of the patient's DNA resulted in the identification of a heterozygous C>G variant at c.204, which resulted in an Ile68Met change in the amino acid. A detailed search of the National Center for Biotechnology Information and the 1000 Genomes databases indicated that the detected variant was unique. According to the SIFT and PolyPhen-2 algorithms, the substitution of Ile to Met was predicted to decrease the activity of the MLH1 protein. The newly identified, functional germline variant was not present in any other CRC patient or control. Thus, a novel germline variant in the MLH1 gene was identified, representing a rare event in sporadic CRC. The occurrence and relevance of this mutation in other types of cancer requires additional investigation.
    WorkplaceInstitute of Experimental Medicine
    ContactArzuv Čaryjeva, arzuv.caryjeva@iem.cas.cz, Tel.: 241 062 218, 296 442 218
    Year of Publishing2016
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.